Literature DB >> 3034319

Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.

T T Kwok, P R Twentyman.   

Abstract

A technique using 'tritiated thymidine suicide' has been established as a means of studying the response to cytotoxic drugs of cells at different depths within multicellular tumour spheroids. Because of the characteristic spatial arrangement of cycling cells (mostly in the outer regions) and non-cycling cells (mostly at the inner regions) of spheroids, cells surviving after long term (24 h) exposure of spheroids to high doses of 3HTdR will be those located furthest from the surface. By comparing the drug response of cells from 3HTdR pre-treated and untreated spheroids, the individual response of total cells, cells near to the surface and cells lying deeper within the viable rim of spheroids can therefore be deduced. In this study, large spheroids of about 800 micron in diameter of a mouse mammary cell line, EMT6/Ca/VJAC, and of a human small cell lung cancer cell line, POC, have been used. Using clonogenic assay, the response of these two cell types to adriamycin (ADM), nitrogen mustard (HN2), CCNU and vincristine (VCR) (POC only) were measured. The preliminary part of this study has confirmed that the cells killed are those which incorporate 3HTdR during the DNA synthesis period; the cells killed are mainly located in the outer regions of spheroids i.e. surviving cells are mostly located in the inner part of the viable rim and 3HTdR pretreatment does not sensitise surviving cells to subsequent cytotoxic drug treatment. Results from large EMT6 spheroids agree with our previous findings (obtained using a selective disaggregation method) that cells in the outer regions of spheroids are more sensitive to ADM and HN2 than cells in the inner regions whilst the opposite is true for CCNU. For POC spheroids, cells in the outer region of spheroids are more sensitive to ADM and VCR than cells in the inner region whilst a reverse trend is seen for the response to CCNU. The response to HN2 is similar at all depths. Amongst the factors governing the response of cells in spheroids to cytotoxic drugs, the responses to ADM and VCR are thought to be largely dictated by cell cycle distribution and limited drug penetrability, whilst for HN2 the response may be determined by the factor of cell cycle distribution. For CCNU, we believe that the cellular response is largely dependent upon microenvironmental factors prevailing within spheroids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034319      PMCID: PMC2001700          DOI: 10.1038/bjc.1987.74

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Changes in cell proliferation kinetics occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; J V Watson; N M Bleehen; P M Rowles
Journal:  Cell Tissue Kinet       Date:  1975-01

2.  A method for measuring the generation time and length of DNA synthesizing phase of clonogenic cells in a heterogenous population.

Authors:  A M Wu
Journal:  Cell Tissue Kinet       Date:  1981-01

3.  A study of factors related to the action of 1-propargyl-5-chloropyrimidin-2-one (NY 3170) and vincristine in human multicellular spheroids.

Authors:  E Wibe; R Oftebro
Journal:  Eur J Cancer Clin Oncol       Date:  1981-09

4.  Use of Hoechst 33342 for cell selection from multicell systems.

Authors:  R E Durand
Journal:  J Histochem Cytochem       Date:  1982-02       Impact factor: 2.479

5.  Chemotherapeutic drugs as indirect oxygen radiosensitizer.

Authors:  F W Hetzel; N Kaufman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-05       Impact factor: 7.038

6.  Selective dissociation and characterization of cells from different regions of multicell tumor spheroids.

Authors:  J P Freyer; R M Sutherland
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

7.  A technique for determining the proportion of the clonogenic cells in S phase in ENT6 cell cultures and tumors.

Authors:  S Rockwell; E Frindel; M Tubiana
Journal:  Cell Tissue Kinet       Date:  1976-07

8.  The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.

Authors:  T T Kwok; P R Twentyman
Journal:  Int J Cancer       Date:  1985-05-15       Impact factor: 7.396

9.  Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

Authors:  H Baillie-Johnson; P R Twentyman; N E Fox; G A Walls; P Workman; J V Watson; N Johnson; J G Reeve; N M Bleehen
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

10.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  4 in total

1.  The murine long-term multi-lineage renewal marrow stem cell is a cycling cell.

Authors:  L R Goldberg; M S Dooner; K W Johnson; E F Papa; M G Pereira; M Del Tatto; D M Adler; J M Aliotta; P J Quesenberry
Journal:  Leukemia       Date:  2013-08-30       Impact factor: 11.528

2.  Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.

Authors:  A Neshasteh-Riz; W J Angerson; J R Reeves; G Smith; R Rampling; R J Mairs
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

Authors:  K O Hicks; S J Ohms; P L van Zijl; W A Denny; P J Hunter; W R Wilson
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.

Authors:  A Neshasteh-Riz; R J Mairs; W J Angerson; P D Stanton; J R Reeves; R Rampling; J Owens; T E Wheldon
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.